The company’s lead drug, ERAS-0015, has shown encouraging early results. On November 20, Erasca will provide updated clinical data that could produce a large move in the stock.
S&P 500 Stock Market Gamma Trading Levels Based on Options Open Interest
The company’s lead drug, ERAS-0015, has shown encouraging early results. On November 20, Erasca will provide updated clinical data that could produce a large move in the stock.